| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MDM2 proto-oncogene | 0.362 | 0.846 | 1.00 |
|
disease | 0.020 | None | < 0.001 | 2 | 0 | 1997 | 2019 | ||||||||
|
Fas ligand | 0.430 | 0.885 | 0.18 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2017 | 2017 | ||||||||
|
splicing factor 3b subunit 1 | 0.511 | 0.731 | 1.00 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2016 | 2019 | ||||||||
|
Cbl proto-oncogene | 0.527 | 0.769 | 6.1E-04 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2012 | 2012 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
disease | 0.030 | None | 0.667 | 3 | 0 | 2012 | 2017 | ||||||||
|
GATA binding protein 1 | 0.483 | 0.808 | 0.95 |
|
disease | 0.040 | None | 0.750 | 4 | 0 | 2004 | 2019 | ||||||||
|
isocitrate dehydrogenase (NADP(+)) 1 | 0.424 | 0.808 | 2.6E-12 |
|
disease | 0.040 | None | 0.750 | 4 | 0 | 2010 | 2016 | ||||||||
|
coagulation factor II, thrombin | 0.415 | 0.885 | 1.1E-03 |
|
disease | 0.040 | None | 0.750 | 4 | 1 | 2005 | 2014 | ||||||||
|
selectin P | 0.460 | 0.769 | 5.0E-32 |
|
disease | 0.040 | None | 0.750 | 4 | 0 | 1999 | 2020 | ||||||||
|
coagulation factor V | 0.441 | 0.846 | 5.9E-15 |
|
disease | 0.040 | None | 0.750 | 4 | 0 | 2002 | 2014 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.330 | None | 0.800 | 5 | 0 | 1996 | 2011 | ||||||||
|
signal transducer and activator of transcription 5B | 0.442 | 0.808 | 1.00 |
|
disease | 0.050 | None | 0.800 | 5 | 0 | 2006 | 2016 | ||||||||
|
isocitrate dehydrogenase (NADP(+)) 2 | 0.434 | 0.808 | 0.88 |
|
disease | 0.060 | None | 0.833 | 6 | 0 | 2010 | 2017 | ||||||||
|
signal transducer and activator of transcription 5A | 0.445 | 0.808 | 1.00 |
|
disease | 0.060 | None | 0.833 | 6 | 0 | 2006 | 2017 | ||||||||
|
sterol O-acyltransferase 1 | 0.424 | 0.846 | 7.4E-10 |
|
disease | 0.070 | None | 0.857 | 7 | 0 | 2007 | 2019 | ||||||||
|
thrombopoietin | 0.513 | 0.692 | 0.20 |
|
disease | 0.400 | None | 0.895 | 19 | 1 | 1995 | 2016 | ||||||||
|
ASXL transcriptional regulator 1 | 0.482 | 0.808 | 1.3E-14 |
|
disease | 0.100 | None | 0.917 | 12 | 0 | 2011 | 2019 | ||||||||
|
BCR activator of RhoGEF and GTPase | 0.431 | 0.885 | 0.99 |
|
disease | 0.100 | None | 0.933 | 15 | 0 | 1991 | 2019 | ||||||||
|
CD177 molecule | 0.595 | 0.654 |
|
disease | 0.100 | None | 0.950 | 20 | 0 | 2000 | 2012 | |||||||||
|
calreticulin | 0.413 | 0.923 | 0.89 |
|
disease | 0.600 | None | 0.969 | 131 | 0 | 2013 | 2020 | ||||||||
|
MPL proto-oncogene, thrombopoietin receptor | 0.510 | 0.692 | 4.1E-09 |
|
disease | 0.500 | None | 0.980 | 101 | 10 | 1994 | 2020 | ||||||||
|
Janus kinase 2 | 0.385 | 0.885 | 0.65 |
|
disease | 0.800 | None | 0.984 | 370 | 8 | 2005 | 2020 | ||||||||
|
ABL proto-oncogene 1, non-receptor tyrosine kinase | 0.432 | 0.923 | 1.00 |
|
disease | 0.100 | None | 1.000 | 34 | 1 | 1991 | 2019 | ||||||||
|
CD34 molecule | 0.368 | 0.808 | 5.0E-06 |
|
disease | 0.100 | None | 1.000 | 10 | 0 | 1999 | 2019 | ||||||||
|
tet methylcytosine dioxygenase 2 | 0.458 | 0.808 | 4.3E-54 |
|
disease | 0.360 | None | 1.000 | 8 | 0 | 2009 | 2016 |